comparemela.com
Home
Live Updates
Ototoxicity Petremann - Breaking News
Pages:
Latest Breaking News On - Ototoxicity petremann - Page 1 : comparemela.com
Sensorion Provides an Update on NOTOXIS, its Proof of Concept Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity (CIO)
MONTPELLIER, France (BUSINESS WIRE) Dec 18, 2023
France general
United states
Lyann nguyen
Institut pasteur
Ototoxicity petremann
Pierre louis germain
Noemie djokovic
Christophe tournigand
European union
World congress
Otolaryngology department
Cochlear ltd
Pure tone audiometry
Cisplatin induced ototoxicity
Chief medical officer
Oncology department
Sensorion Announces First Patient Enrolled in Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity
Regulatory News: Sensorion (FR0012596468 ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the
United states
Ototoxicity petremann
Institut pasteur
Noemie djokovic
Matthew cole jessica hodgson
European union
International media relations
Consilium strategic communications
Regulatory news
Cisplatin induced ototoxicity
Chief medical officer
Sudden sensorineural hearing loss
Pure tone audiometry
Orphan drug designation
Cochlear limited
Strategic communications
vimarsana © 2020. All Rights Reserved.